J Samuelsson, M Mutschler, G Birgegard, P Gram-Hansen, M Bjorkholm, HL Pahl. Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia. haematol [Internet]. 2006Sep.1 [cited 2024Dec.21];91(9):1281-2. Available from: https://haematologica.org/article/view/4163